Profile data is unavailable for this security.
About the company
The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.
- Revenue in HKD (TTM)15.95bn
- Net income in HKD3.46bn
- Incorporated--
- Employees17.40k
- LocationUnited Laboratories International Holdings Ltd6 FuK Wang StreetYuen Long Industrial EstateYuen Long Hong KongHKG
- Phone+852 26871033
- Fax+852 26871031
- Websitehttps://www.tul.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Ltd | 3.45bn | -1.62bn | 16.38bn | 1.87k | -- | 2.70 | -- | 4.74 | -1.52 | -1.52 | 3.21 | 5.37 | 0.4119 | 3.19 | 6.53 | -- | -19.29 | -33.80 | -27.61 | -39.12 | 61.52 | 64.07 | -46.83 | -186.77 | 2.68 | -- | 0.2108 | -- | 49.59 | 98.38 | 23.17 | -- | 32.19 | -- |
| Ascletis Pharma Inc | 2.67m | -292.43m | 17.87bn | 208.00 | -- | 7.68 | -- | 6,683.74 | -0.2989 | -0.2989 | 0.0027 | 2.19 | 0.0011 | 0.2668 | 11.59 | 11,573.89 | -12.10 | -8.46 | -12.73 | -8.80 | 36.21 | 7.91 | -10,937.78 | -522.12 | 14.53 | -- | 0.0023 | -- | -97.73 | -62.52 | -107.95 | -- | -40.26 | -- |
| Vigonvita Life Sciences Co Ltd | -100.00bn | -100.00bn | 18.10bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -94.07 | -- | -1,848.73 | -- | -- | -- |
| Ab&B Bio Tech Co Ltd JS | 366.15m | -253.82m | 20.18bn | 583.00 | -- | 530.23 | -- | 55.12 | -0.6451 | -0.6451 | 0.9306 | 0.0968 | -- | -- | -- | -- | -- | -- | -- | -- | 67.29 | -- | -69.32 | -- | 0.3162 | -9.49 | 0.9646 | -- | 397.65 | -- | 39.09 | -- | -- | -- |
| HUTCHMED (China) Ltd | 4.71bn | 3.65bn | 20.22bn | 1.78k | 5.54 | 2.10 | 5.39 | 4.30 | 4.18 | 4.18 | 5.39 | 11.02 | 0.3966 | 7.09 | 3.86 | 2,599,556.00 | 30.79 | -9.55 | 40.72 | -13.77 | 44.15 | 39.84 | 77.64 | -20.32 | 4.51 | -- | 0.07 | -- | -24.80 | 25.20 | -62.56 | -- | 15.93 | -- |
| Sunshine Lake Pharma Co Ltd | 3.82bn | -447.80m | 24.19bn | 6.53k | -- | 54.74 | 20,257.62 | 6.34 | -0.7765 | -0.7765 | 6.62 | 0.7672 | -- | -- | -- | 582,679.50 | -- | -- | -- | -- | 73.62 | -- | -12.86 | -- | 0.7739 | -0.7591 | 0.5111 | -- | -37.06 | -- | -212.17 | -- | -- | -- |
| The United Laboratories Intl. Hldgs Ltd. | 15.95bn | 3.46bn | 24.90bn | 17.40k | 6.62 | 1.30 | 5.98 | 1.56 | 1.91 | 1.91 | 8.78 | 9.69 | 0.5397 | 2.89 | 5.97 | 938,145.00 | 11.71 | 9.37 | 17.46 | 14.54 | 47.24 | 44.33 | 21.70 | 15.06 | 1.60 | -- | 0.2472 | 26.01 | 0.1387 | 10.39 | -1.54 | 32.89 | 37.25 | 45.96 |
| Shanghai Henlius Biotech Inc | 6.56bn | 932.24m | 24.90bn | 3.54k | 41.95 | 10.15 | 17.65 | 3.80 | 1.72 | 1.72 | 12.06 | 7.09 | 0.5386 | 1.73 | 5.86 | 1,865,468.00 | 7.66 | -3.21 | 13.85 | -5.76 | 75.77 | 72.50 | 14.22 | -7.87 | 0.5046 | 10.47 | 0.5185 | -- | 6.11 | 128.98 | 50.26 | -- | 10.83 | -- |
| PegBio Co Ltd | -100.00bn | -100.00bn | 26.11bn | 58.00 | -- | 89.25 | -- | -- | -- | -- | -- | 0.7479 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.07 | -- | 0.2439 | -- | -- | -- | -1.49 | -- | -- | -- |
| Grand Pharmaceutical Group Ltd | 11.70bn | 2.08bn | 26.83bn | 12.44k | 12.72 | 1.54 | 10.35 | 2.29 | 0.5943 | 0.5943 | 3.35 | 4.90 | 0.4557 | 3.66 | 3.88 | 976,472.80 | 7.99 | 10.40 | 10.81 | 14.24 | 57.64 | 61.04 | 17.53 | 22.80 | 0.9872 | -- | 0.2107 | 29.12 | 10.59 | 12.06 | 31.30 | 16.49 | 0.7398 | 22.05 |
| China Resources Pharmaceutical Group Ltd | 295.11bn | 3.19bn | 29.34bn | 86.00k | 9.19 | 0.5192 | 2.25 | 0.0994 | 0.5083 | 0.5083 | 46.97 | 8.99 | 0.9434 | 5.57 | 2.41 | 4,059,329.00 | 2.86 | 3.14 | 10.28 | 11.78 | 15.81 | 15.59 | 3.03 | 3.02 | 1.12 | 11.26 | 0.4248 | 22.38 | 5.30 | 7.41 | -13.06 | 2.95 | 12.42 | 7.30 |
| Duality Biotherapeutics Inc | 2.45bn | -3.20bn | 29.48bn | 191.00 | -- | 8.74 | -- | 12.01 | -36.93 | -36.93 | 28.67 | 37.42 | -- | -- | -- | 14,438,690.00 | -- | -- | -- | -- | 37.13 | -- | -130.43 | -- | -- | -- | 0.0228 | -- | 8.66 | -- | -193.82 | -- | -- | -- |
| Simcere Pharmaceutical Group Ltd | 8.04bn | 995.43m | 31.88bn | 6.82k | 30.35 | 3.71 | 22.87 | 3.97 | 0.4047 | 0.4047 | 3.26 | 3.31 | 0.5845 | 2.20 | 2.81 | 1,220,719.00 | 7.24 | 8.74 | 9.93 | 12.42 | 81.00 | 78.53 | 12.39 | 15.60 | 1.57 | 4.72 | 0.1453 | 44.12 | 0.4148 | 5.67 | 2.57 | -6.09 | 8.48 | -- |
| Xuanzhu Biopharmaceutical Co Ltd | 36.14m | -629.22m | 33.93bn | 197.00 | -- | 35.47 | -- | 938.68 | -1.21 | -1.21 | 0.0698 | 1.85 | -- | -- | -- | -- | -- | -- | -- | -- | 41.02 | -- | -1,740.97 | -- | 1.10 | -- | 0.0013 | -- | 103,672.40 | -- | -85.13 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to United Laboratories International Holdings Ltd's reporting currency: Hong Kong Dollar HKD
10.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 07 Jan 2026 | 42.09m | 2.13% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 35.00m | 1.77% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 23.90m | 1.21% |
| American Century Investment Management, Inc.as of 08 Jan 2026 | 22.63m | 1.15% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 16.79m | 0.85% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 14.49m | 0.74% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 13.05m | 0.66% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 12.88m | 0.65% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Dec 2025 | 9.71m | 0.49% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 7.68m | 0.39% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
